• xxx

COLQUHOUN, Ms Alexandra

Alex studied medicine at the University of Leicester before subsequently training in Urology in the East Midlands.  She then headed to Toronto for two years to undertake further specialist training in urological oncology obtaining membership of the American Society of Urologic Oncology.  She was appointed as a Consultant Urologist at Addenbrooke’s Hospital in Cambridge in 2011 and has a specialist interest in the treatment of bladder cancer.

 

Alex is the current lead of the Bladder Oncology Team at Addenbrooke’s that specialises in the management of high-risk bladder and muscle invasive cancer.  This includes use of a number of non-surgical approaches (eg intravesical BCG therapy) as well as to radical robotic surgery to remove the bladder and a full range of reconstructive urinary diversion techniques, including neobladder formation.

 

Alex’s is currently the Clinical Director for Cancer at Addenbrooke’s Hospital, a role that involves responsibility for ensuring high quality care for patients with a broad range of tumour types.  She is also the current Honorary Secretary of the British Association of Urological Surgeons Section of Oncology.  Her interest in the management of bladder cancer has seen her involvement as a committee member for both the 2012 International Consultation on Urological Diseases consultation on Bladder Cancer (http://www.icud.info/bladdercancer2nd.html) and also the NHS Shared Decision Making project creating a patient decision aid for patients with bladder cancer (http://sdm.rightcare.nhs.uk/pda).  She was also an executive committee member contributing to the recent Urology Getting It Right First Time bladder cancer workstream

UK Oncology Forum 2022

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.